期刊
MOLECULAR PHARMACEUTICS
卷 13, 期 6, 页码 1800-1808出版社
AMER CHEMICAL SOC
DOI: 10.1021/acs.molpharmaceut.5b00952
关键词
ABC phenomenon; complement activation; liposomes; hyaluronic acid
资金
- National Basic Research Program of China (973 program) [2013CB932504]
- National S & T Major Project of China [2012ZX09304004]
- National Science Foundation of PR China [81273443]
PEGylated liposomes (PEG-Lip) have been widely used as a drug carrier for their good stealth property in blood circulation. However, the second injection of PEG-Lip was reported to result in the accelerated blood clearance (ABC) phenomenon and trigger hypersensitivity reactions in sensitive individuals for its complement activation effect. To avoid adverse immune responses, HA was selected to modify liposomes to afford HA modified liposomes (HA-Lip). Repeated administrations of PEG-Lip and HA-Lip were performed in rats. Our results showed that PEG-Lip induced the ABC phenomenon accompanied by a greatly increased accumulation of PEG-Lip in the liver. In contrast, HA-Lip showed good stealth property without inducing either the ABC phenomenon or an increase in liver uptake. Moreover, HA-Lip did not trigger complement activation in human serum in vitro and in rat blood in vivo. Consequently, HA modification represents a viable strategy to prolong the blood circulation time of liposomes without inducing the ABC phenomenon and adverse immune responses.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据